Christine Hill-Kayser, MD

University of Pennsylvania
Philadelphia, PA

Disclosures:

  • Employment: U Penn:Faculty:Employee
  • Compensation: :Role Topic Description-End Date:
  • Ownership: none
  • Leadership: none

Presentations

Sep 27

2329 - A Phase III Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Lorlatinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (ANBL1531)
Poster Hall - Exhibit Hall A
04:00pm - 05:00pm ET
Sep 28

2752 - Design and Implementation of Survivorship Care Plans for Adolescents and Young Adults Diagnosed with Thyroid Malignancies
Poster Hall - Exhibit Hall A
03:00pm - 04:00pm ET